Report Highlights
The global market for home medical equipment (HME) was worth $17.9 billion in 2010, nearly $19 billion in 2011, and is expected to reach $26.2 billion by 2016, a CAGR of 6.7%.
Report Scope
This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the global market for home medical equipment. Home medical equipment is defined as durable equipment (i.e., equipment with an expected service life of at least three years) that:
- Can withstand repeated use.
- Is primarily and customarily used to serve a medical purpose.
- Generally is not useful to a person in the absence of an illness or injury.
- Is not implanted inside the patient’s body.
- Is appropriate for use in the home.
- Does not require a trained medical professional to operate.
- Usually requires a doctor’s prescription to buy (e.g., excludes most canes, walkers and other elderly and disabled assistive devices).
- Generally does not include drugs and other consumables.
While the report’s coverage is global, it focuses on selected international markets for HME, including:
- North America (United States, Canada).
- European Union (France, Germany, Italy, U.K., other European countries).
- Japan.
- BRIC nations (Brazil, Russia, India, China).
- Rest of the world.
The report includes sections on the following topics:
- Major product types and applications, both commercial and developmental.
- Market size and segmentation, including historical data on sales by product type and geographical market.
- Market drivers and constraints.
- Detailed market projections through 2016.
- Patent analysis.
- Competitor profiles.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
-
The global market for home medical equipment (HME) was worth about $16.8 billion in 2009. BCC expects the HME market to grow to $17.7 billion in 2010 and $23.8 billion by 2015, a CAGR of 6.1% over the next 5 years.
-
The market for therapeutic HME as a group is the fastest growing segment; their share of the total global HME market is expected to increase from about 23% to 28% by 2015. Therapeutic HME was valued at $3.9 billion in 2009 and $4.3 billion in 2010 and will be worth an estimated $6.7 billion by 2015, a compound annual growth rate (CAGR) of 9.3%.
-
Monitors, sensors, and telemetry devices account for the largest share of the HME market, mainly because of the very large market for home blood glucose testers. This segment was worth $7.7 billion in 2009 and $8 billion in 2010. By 2015, this sector will be worth an estimated $11.3 billion, a compound annual growth rate (CAGR) of 7%.
Report Highlights
-
The global home medical equipment market increased from about $13.9 billion in 2006 to an estimated $14.6 billion in 2007. It should reach $20.4 billion by 2012, a compound annual growth rate (CAGR) of 6.8%.
-
The United States and Canada together form the largest geographical market for HME, i.e, 34.2% of the global market.
-
Among the various diseases managed or treated with HME, diabetes accounts for the largest share (i.e., 46.2% in 2006) of the global HME market.
Related Reports
Medical Automation Technologies, Products and Markets
The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.
Disabled and Elderly Assistive Technologies
The U.S. market for assistive technologies is projected to grow from $39.5 billion (including eyeglasses and contact lenses) in 2010 to $41.1 billion in 2011 and $55 billion in 2016, a compound annual growth rate (CAGR) of 6% between 2011 and 2016.
Healthcare Information Technology
BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010. The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.
Telemedicine: Opportunities for Medical and Electronic Providers
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, at a compound annual growth rate (CAGR) of 18.6% over the next 5 years.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More